The revised National Food Safety Standard for Good Manufacturing Practice of Health Foods will be released soon.
In Sept. 2025, Henan Taifeng Bio was officially launched its new drug, Menaquinone Soft Capsules.
In Sept. 2025, Aland's shareholders are considering selling their collectively held shares, with the equity valuation expected to exceed USD1.5 billion.
Project Progress of Multiple Companies
- Haineng Bio's 25-Hydroxyvitamin D3 production base project has entered the core equipment installation and commissioning stage.
- EI report for Hegno Pharma's vitamin project was approved.
- EI report for Chifeng Pharma's vitamin B2, griseofulvin relocation and renovation project was publicized.
The USD/RMB exchange rate in this Report is USD1.00=CNY7.1072 on 1 Sept. 2025, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
